scholarly journals Good long-term outcome of Budd-Chiari syndrome with a step-wise management

Hepatology ◽  
2013 ◽  
Vol 57 (5) ◽  
pp. 1962-1968 ◽  
Author(s):  
Susana Seijo ◽  
Aurelie Plessier ◽  
Jildou Hoekstra ◽  
Alessandra Dell'Era ◽  
Dalvinder Mandair ◽  
...  
Keyword(s):  
Budd Chiari Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chiari Syndrome

Percutaneous recanalization for combined-type Budd–Chiari syndrome: strategy and long-term outcome

2015 ◽  
Vol 40 (8) ◽  
pp. 3240-3247 ◽  
Author(s):  
Yu-Fei Fu ◽  
Yu Li ◽  
Yan-Feng Cui ◽  
Ning Wei ◽  
De-Chun Li ◽  
...  
Keyword(s):  
Budd Chiari Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chiari Syndrome ◽  
Percutaneous Recanalization

Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms

2015 ◽  
Vol 35 (8) ◽  
pp. 2042-2049 ◽  
Author(s):  
Andrej Potthoff ◽  
Dina Attia ◽  
Sven Pischke ◽  
Ingmar Mederacke ◽  
Gernot Beutel ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Myeloproliferative Neoplasms ◽  
Budd Chiari Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Transplant Patients ◽  
Chiari Syndrome

scholarly journals Budd-Chiari syndrome managed with percutaneous recanalization: Long-term outcome and comparison with medical therapy

2019 ◽  
Vol 8 (2) ◽  
pp. 74-81
Author(s):  
Chinmay Bhimaji Kulkarni ◽  
Srikanth Moorthy ◽  
Sreekumar Karumathil Pullara ◽  
Nirmal Kumar Prabhu ◽  
Ramiah Rajesh Kannan ◽  
...  
Keyword(s):  
Medical Therapy ◽  
Budd Chiari Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chiari Syndrome ◽  
Percutaneous Recanalization

scholarly journals Timing of transjugular intrahepatic portosystemic stent-shunt in Budd–Chiari syndrome: A UK hepatologist's perspective

2018 ◽  
Vol 6 (3) ◽  
pp. 97-104 ◽  
Author(s):  
Faisal Khan ◽  
Homoyon Mehrzad ◽  
Dhiraj Tripathi
Keyword(s):  
Liver Failure ◽  
Refractory Ascites ◽  
Budd Chiari Syndrome ◽  
Venous Outflow ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chiari Syndrome ◽  
Hepatic Venous Outflow ◽  
Liver Replacement

Abstract Budd–Chiari syndrome (BCS) is a rare but fatal disease caused by the obstruction in hepatic venous outflow tract (usually by thrombosis) and is further classified into two subtypes depending on the level of obstruction. Patients with BCS often have a combination of prothrombotic risk factors. Clinical presentation is diverse. Stepwise management strategy has been suggested with excellent 5-year survival rate. It includes anticoagulation, treatment of identified prothrombotic risk factor, percutaneous recanalization, and transjugular intrahepatic portosystemic shunt (TIPS) to reestablish hepatic venous outflow and liver transplantation in unresponsive patients. Owing to the rarity of BCS, there are no randomized controlled trials (RCTs) precisely identifying the timing for TIPS. TIPS should be considered in patients with refractory ascites, variceal bleed, and fulminant liver failure. Liver replacement is indicated in patients with progressive liver failure and in those in whom TIPS is not technically possible. The long-term outcome is usually influenced by the underlying hematologic condition and the development of hepatocellular carcinoma. This review focuses on the timing and the long-term efficacy of TIPS in patients with BCS.

Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome

2008 ◽  
Vol 28 (2) ◽  
pp. 249-256 ◽  
Author(s):  
Sarwa Darwish Murad ◽  
Trinh K. Luong ◽  
Peter M. T. Pattynama ◽  
Bettina E. Hansen ◽  
Henk R. Van Buuren ◽  
...  
Keyword(s):  
Transjugular Intrahepatic Portosystemic Shunt ◽  
Portosystemic Shunt ◽  
Budd Chiari Syndrome ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Chiari Syndrome ◽  
Intrahepatic Portosystemic Shunt
Sign in / Sign up

Export Citation Format

Share Document